ADGM Adagio Medical Holdings Inc.

$ADGM FDA ✅ very bullish 💹 Adagio Medical Highlights First Patient Treated in IDE Study Evaluating Next-Generation vCLAS™ Ultra System for Ventricular Tachycardia at Banner --University Medical Center Phoenix 💹 The supplemental study is being conducted under the Company's FDA-approved Investigational Device Exemption ("IDE") designed to evaluate the safety and effectiveness of the VCLAS Ultra System for the treatment of Sustained Monomorphic Ventricular Tachycardia ("SMVT").💹

$ADGM What is the difference between companies like these and Chinese firms often labeled as fraudulent? The outcome is the same: the loss of your money. In fact, these companies are even worse than Chinese firms—with the latter, you operate from a position of mistrust, whereas here, you place your trust in them and invest based on their promises, only to find that at the first sign of a crisis, small shareholders are the first to be sacrificed.

$ADGM break .16 all this accumulation has biggest institutional holding of most the penny plays squeezing should gooo like $AMOD $SDEV $DDC $QTEX let’s goooo 🚀🚀

$ADGM 4 conferences next week let’s gooo $7.7m cash in hand that’s .35/share! Chart bounce at .20 to reclaim

$ADGM I learned another life lesson - if the executive team has a Harvard or Wharton background - do not invest in it - your money is considered their personal money, in my opinion.

$ADGM keep in mind: PMA submission was obviously accepted. 180 Day clock started at 21th May or a few days earlier. >>> Today is 119 Day of review period (if no holds occured). Day 100 meeting should already happened. Day 180 would be around 17th November. <<< Farapulse (also BDD) got approved after Day 137, that would be early October in our case. - Fingers crossed it's getting hot in here. Still betting on PMA approval before any capital raise.

$ADGM Let’s gooo market green let’s squeeze shorts here targets .18 .21 .28 off the chart!

$ADGM has the highest institutional ownership out of all penny stocks under $1 currently. Follow the $$

$ADGM traded nicely good volume could open big tomorrow has big FDA catalyst setup like $FNGR $QSI we banked on

$ADGM I accept it - it is an obsolete technology. Only have 1k shares left - not worth selling - will paper a wall with it. Are all CEO's evil or just incompetent?

$ADGM is a Delaware corporation, so the Board’s actions are governed by Delaware fiduciary law. In simple terms, directors are expected to: • Act on an informed basis and understand the material economic consequences of transactions they approve. • Act loyally and in good faith for the corporation and its stockholders, particularly where insiders, lenders or other parties may have interests different from common shareholders. • Evaluate conflicts and use an appropriate independent process where conflicts exist. • In an actual sale-of-control process, seek the best value reasonably available to stockholders under Delaware’s Revlon framework. The question isn’t just whether the today’s actions are legal. The question is: Did the Board understand this consequences, model them, consider the effect on shareholders, and approve the change in terms through an informed and appropriately independent process?

$ADGM Look at website - little d-s company has 4 C level , couple of SVP, like 9 Executives to stroke each other - I bet the separation packages for these slugs wipe out the rest of stare holder value.

$ADGM is going to need money soon. Dilution at these valuations is almost like giving the company away. Company is omitting PR on positive catalysts to investors, which at this point with the immediate need to raise equity is costing shareholders money. A PR stating that the PMA was accepted for review by the FDA was a material catalyst. The 100 day meeting window is approaching and any relevant feedback disclosure should be planned now especially considering management targets approval near the end of this year. Positive feedback is a catalyst and should be used, issues that are discussed at this point are likely material information as well that need to be disclosed as it could extend the timing if negative. Lack of IR is negatively impacting the company valuation. Where are the conferences? Cardiovascular Tech Forum is THIS week, it's 20 MINUTES from the office. HFSA, TCT start next month all in the South Eastern US. Show up ? Disclosure: I own 200K+ shares.

$ADGM If you knew anything about Pulse Field Ablation (PFA) you would understand why Adagio could not raise the capital needed to continue. All of the bigs, J&J, Boston Sci, Medtronic, Abbott, have developed new PFA technologies for Afib & VT ablation. Cryo is obsolete

$ADGM .. $.21 .. THE chairperson of the $ADGM Board of Directors is the managing director for Perceptive Advisors who (Perceptive) own 50% of the company! They also have another Perceptive Advisor Director on the board.🤔 I think Perceptive could use this shell to spin it out again w/ the financing they need from their original backers. Perceptive, Adar1, & Sio.

$ADGM Adagio's tech has clear value, which is why the board is explicitly looking for a merger, corporate acquisition, or outright asset sale. The Best Case: A major medical device player (like Boston Scientific or Medtronic) buys Adagio out for its ULTA patent portfolio, potentially offering a premium on the depressed stock price.

$ADGM Sorry Longs. Maybe the best time to buy is around Xmas (tax loss season) and hope for a buyout.

$ADGM I’m sending IR/the Board an information request regarding today’s conversion-price change, including the Section 5(b) Change of Control economics, independent Board review, dilution analysis and Nasdaq treatment. If you’re an ADGM shareholder and would simply like to be CC’d on the request and any potential response, feel free to DM me your email address.

$ADGM October 10 is the Financial Covenant deadline — the tenth day after Q3 ended on September 30. From Section 14(q)(ii) of the note: "If the Financial Test fails to be satisfied, a statement to that effect no later than the tenth day after the end of such Fiscal Quarter" The Financial Test requires $4M minimum Available Cash at quarter end.

$ADGM dilution on tap for the entire month of October. The good news is they only have 210 mil authorized shares. 🤮